Diving since he was 4 and always seeking the thrill of discovery, he was part of the crew of his grandfather's storied ships, Calypso and Alcyone at the age of 12. Over the next 11 years he has been collecting priceless experiences during expeditions to exotic places. The combination of his fieldwork and a degree in environmental economics from Boston University has developed his strong belief that discipline can be the basis for innovative solutions that reconcile regional and global environmental problems with western market economies. A perfect example of such a resolution, he maintains, is the world wide growth of eco-tourism. "Take, for example, the Great White sharks in South Africa," he said. “These beautiful fish are protected and well respected in that part of the world mainly because an economic solution has permitted locals to make a living by preserving rather than killing. The future well-being of our planet rests in our convincing people that the environment is worth saving." It is with this thought that he set out to show what could be done in the business world. Fabien successfully spearheaded new product development and new business project models for environmental sustainability over the next few years. Having proven his skills in business, he decided to return to his deep-rooted family passion for exploration. He joined his father, Jean-Michel, and Deep Ocean Odyssey, as the third generation to carry on the tradition of adventure and exploration in the deep ocean, pioneered by his grandfather more than half a century ago. Recently he co-launched Natural Entertainment, which is working on numerous projects related to exploration and environmental awareness thru television and other media. Currently, Fabien has partnered up with his father, Jean Michel Cousteau, and sister Celine to complete a three year multi hour series called Ocean Adventures for PBS starting in 2006 (http://www.pbs.org/kqed/oceanadventures). Topics range from the Grey whale migration of the west coast of the Americas to the magical coral spawning of the Caribbean to diving with squadrons of goliath groupers to the ghost ships of the Great Lakes. Additional hours cover exotic places such as the Amazon, Samoa, Christmas Island, Papua New Guinea, the Arctic and so on. The most recent expeditions covering the topics of Belugas, Orcas and man will air on PBS in April of 2009. Fabien is also embarked on several personal projects such as his new initiative to actively involve the public in undersea restoration initiatives coupled with government protection of the restored areas. He also partners with outside initiatives such as savebimini.org in an effort to impassion people into changing the tide of current events that threaten to blindly destroy the environmental wealth of our future generations. During his “down-time” Fabien is working on designing and building and Oceans Educational Institute as part of several educational institutions around the United States. An active writer, he is currently working on a children’s book trilogy. Other writings include articles in several international publications. Fabien shares his time between France and the United States and when not conducting fieldwork he is riding the planet on a wind surfer, mountain bike or piloting a plane. His passion for vintage motorcycles sometimes takes him to the quiet of his garage where his cellphone does not work and he can dive into the zen of breathing life into these "basket cases".
George Thompson manages technical government programs in support of Intel’s long term technology strategy. This includes developing collaborations among multiple companies, universities and government entities in public - private partnerships using open innovation frameworks to facilitate mutual support and technology transfer. He currently serves on a number on university and government advisory boards. He has a PhD in Physical Chemistry and was awarded a National Research Council Post Doctoral Fellowship at NIST. Prior to working at Intel he was a staff scientist at the Paul Scherrer Institute in Switzerland working in the research and development of solar energy and applications of high resolution molecular spectroscopy. He has also done research and development for space electronics, optical diagnostic methods, and semiconductor manufacturing processes.
Chairman, Research and Education Subcommittee of the House Science and Technology Committee Congressman Dan Lipinski is a proud native and Representative of Illinois’ Third Congressional District. The district includes large parts of south and southwest Chicago, as well as several suburban communities in west and southwest Cook County. All of these neighborhoods and the families who call them home make the Third District one of the most diverse and vibrant areas in the entire country. As a skilled legislator, Congressman Lipinski has fought tirelessly for the residents of the district, as well as all Americans-leading the way in improving our nation’s schools, making the healthcare system more accessible and transparent, strengthening Social Security and Medicare, protecting the American worker, improving our nation’s transportation and infrastructure, and ensuring our families’ safety and security. To advance the interests of the Third District, Congressman Lipinski is a member of three House Committees: Transportation and Infrastructure, Science and Technology, and Small Business. As a member of the House Committee on Transportation and Infrastructure, Congressman Lipinski serves on the Subcommittee on Aviation, the Subcommittee on Highways and Transit, and the Subcommittee on Railroads, Pipelines, and Hazardous Materials. In the Committee on Science and Technology, Congressman Lipinski is Vice-Chairman of the full Committee and also a member of the Subcommittee on Research and Science Education and the Subcommittee on Energy and Environment. As a member of the House Committee Small Business, Congressman Lipinski belongs to the Subcommittee on Regulations, Healthcare and Trade. Prior to his election to the House of Representatives, Congressman Lipinski taught Political Science at the University of Tennessee and at the University of Notre Dame. He served on the staffs of former Minority Leader Richard Gephardt, Congressman Lane Evans, Congressman Jerry Costello, former Congressman George Sangmiester, and former Congressman Rod Blagojevich. He also served on the staffs of the House Administration Committee and the House Democratic Policy Committee and worked for the U.S. Department of Labor and the Illinois General Assembly’s Commission on Intergovernmental Cooperation. Congressman Dan Lipinski earned a Bachelor’s Degree in Mechanical Engineering from Northwestern University, a Master’s Degree in Engineering-Economic Systems from Stanford University, and a PhD in Political Science from Duke University.
George M. Scalise is President of the Semiconductor Industry Association (SIA), an association of semiconductor manufacturers and suppliers, focused on International Trade & Government affairs, Workforce, Technology, and environmental Safety & Health. Mr. Scalise came to SIA from Apple Computer, Inc., where he served as Executive Vice President and Chief Administrative Officer. Prior to that, he held executive management positions at National Semiconductor, Maxtor Corporation, Advanced Micro Devices, Fairchild Semiconductor and Motorola Semiconductor. Mr. Scalise was Chairman of the Board of the Federal Reserve Bank of San Francisco and Chairman of the Executive Committee of the Conference of Chairman of the Federal Reserve System. He also served on President Bush’s Council of Advisors on Science and Technology. He is currently on the corporate boards of MindTree Limited, Intermolecular Corporation and Cadence Design Systems. He was a member of the Advisory Board of the School of Engineering at the University of Southern California and Purdue University. He served on the boards of SEMATECH, Semiconductor Research Corporation, Bay Area Economic Forum and the Council on Foreign Relations Economic Task force on Japan. He served on the California Council on Science and Technology and was a member of the Joint High-Level Advisory Panel of the United States-Israel science and Technology commission, and chaired the Secretary of Energy Advisory Board, US Department of Energy. Mr. Scalise is a graduate of Purdue University with a B.S. in mechanical engineering and was awarded the Distinguished Engineering Alumni Award from Purdue in 2002.
Don Thompson is president of The Oil Sands Developers Group (OSDG). As president, Mr. Thompson is chair of the OSDG’s Board of Directors, which determines the group’s position on various issues that are brought forward by the members for collaborative consideration, action and resolution. Mr. Thompson is also a spokesperson for the OSDG and he is often called upon to interact with key stakeholders such as government ministers, mayors and councils. The OSDG is responsible for ensuring the 26-member group accomplishes its vision of energizing sustainable communities. The group’s mandate is to ensure information dissemination to government, key stakeholders and other interested parties about industry perspectives while consulting with stakeholders and bringing forward issues and challenges for the orderly development of Alberta’s oil sands deposits. Don Thompson has worked for Syncrude since 1979 and became Corporate Secretary and General Manager of Environment, Health and Safety. He was appointed as an Officer in 1988 and remained in that position until 2007. Over this period, his responsibilities included ensuring the governance of Syncrude was managed professionally and ethically. He also acted as a liaison between Syncrude and its owners and shareholders. Mr. Thompson also focused on Syncrude’s regulatory and external affairs with particular emphasis on responding to the large number of environmental and external relationship challenges facing Syncrude – a position directly related to his work with the OSDG – and on mentoring of the “next generation” of Syncrude expertise. Since 2007, Mr. Thompson has focused on his role as president of the OSDG while remaining on active duty with Syncrude. Mr. Thompson’s extensive experience with the oil sands industry in combination with his educational background in forestry, zoology, executive and financial management has earned him a reputation as a trusted and reliable source to lead and speak on behalf of the OSDG.
Mark A. Shannon is the Director of the NSF STC WaterCAMPWS, which is a multiple university and government laboratory center for advancing the science and engineering of materials and systems for revolutionary improvements in water purification for human use. He is also the Director of the Micro-Nano-Mechanical Systems (MNMS) Laboratory at the University of Illinois at Urbana-Champaign, a 2000 sq. ft class 10 and 100 cleanroom laboratory devoted to research and education in the design and fabrication of micro- and nanoelectromechanical systems (MEMS & NEMS), microscale fuel cells and gas sensors, high-temperature microchemical reactors, micro-nanofluidic sensors for biological fluids. He chaired the Instrument Systems Development Study Session for the National Institutes of Health. He is the James W. Bayne Professor of Mechanical Engineering, and received his B.S. (1989) M.S. (1991) and Ph.D. (1993) degrees in Mechanical Engineering from the University of California at Berkeley. He received the NSF Career Award in 1997 to advance microfabrication technologies, the Xerox Award for Excellence in Research (2004), the Kritzer Scholar (2003-2006), the Willet Faculty Scholar (2004-2007), and received the BP Innovation in Education Award in 2006.
Hank joined SAIL in January 2006 as a pioneering figure in the areas of environmental business and policy and a leading contributor to environmental innovation. He has been influential in spearheading many of SAIL's portfolio company investments. Hank and Managing Partner Walter Schindler are responsible for co-managing all aspects of SAIL’s operations and investments. His career as a leading member of the environmental policy world has included leadership positions at the U.S. Department of Justice as Assistant Attorney General in charge of the Environment and Natural Resources Division, and at the U.S. EPA as COO (Deputy Administrator). During his time with the EPA he oversaw the development of new air and water programs to prevent pollution, including the development of the Energy Star program and implementation of market based trading programs under the 1990 Clean Air Act amendments. In business, Hank served as Senior VP in charge of acquisitions and other divisions of Safety-Kleen, a billion-dollar environmental service company. He has also held positions and started ventures in the for-profit environmental arena, including VP of William D. Ruckelshaus Associates, which co-managed the successful Environmental Venture Fund, one of the first successful green funds in the 1980s. As Co-Founder of Capital E, LLC, a strategic consultancy for emerging renewable energy products and technologies, he advised Fortune 100 and early stage ventures on sustainable growth strategies. He previously served as CEO and is now Vice Chairman of a prestigious non-for-profit corporation that fosters innovation in environmental management and promotes applications of clean technology in emerging markets, called Global Environment & Technology Foundation (GETF.) Hank has held numerous Board seats over the years, currently he sits on the Boards of SAIL companies WaterHealth International, and Xtreme Power, and is a Co-Founder of the American Council of Renewable Energy. He is Commissioner of the National Commission on Energy Policy, has advised several Cabinet Secretaries. He is on the Advisory Board to the National Renewable Energy Lab and the Pacific Northwest National Lab. In 1991 the EPA awarded him with the esteemed Total Quality Leadership Award and in 2009 he received the national Richard Mellon Award for Environmental Stewardship. Hank holds a Bachelors degree with High Honors from Princeton University and a J.D. from the University of Virginia.
Clayton Teague is Director of the federal National Nanotechnology Coordination Office (NNCO) since April 2003. Established in 2001, the NNCO is the secretariat to the Nanoscale Science, Engineering and Technology Subcommittee of the NSTC. As such, the NNCO provides day-to-day technical and administrative support to the NSET Subcommittee and assists in the preparation of multi-agency planning, budget and assessment documents. The NNCO is the point of contact on federal Nanotechnology activities for government organizations, academia, industry, professional societies, foreign organizations, and others to exchange technical and programmatic information. In addition, the NNCO develops and makes available printed and other materials as directed by the NSET Subcommittee as well as maintains the NNI Web site. Dr. Teague was previously Chief of the Manufacturing Metrology Division in the Manufacturing Engineering Laboratory of the National Institute of Standards and Technology (NIST). At NIST since 1972, Dr. Teague has designed, constructed, and used precision instrumentation for ultra-high accuracy dimensional metrology of surfaces and micrometer to nanometer-scale features. Beginning with his metal-vacuum-metal tunneling work in the 1970’s, he continued to work with such precision instrumentation as scanning tunneling microscopes, atomic force microscopes, displacement and phase-measuring interferometry, stylus instruments, flexure stages, and light scattering apparatus. Because the laboratory and building environments were always factors in the ultimate performance of these instruments, the subject of this workshop has been an ongoing topic of great interest. Dr. Teague is a member of the American Society for Precision Engineering, has served twice as the Society’s President, and is a fellow of the UK Institute of Physics. He served as Editor-in-Chief of the international journal Nanotechnology for ten years and is currently a member of the Editorial Board of the journal. He holds a B.S. and M.S. in physics from the Georgia Institute of Technology and a PhD in physics from the University of North Texas. He has authored or coauthored 70 papers, has presented 50 invited talks in the technical fields described, and jointly with colleagues, has six patents. Dr. Teague has received the Gold Medal, Silver Medal, and Allen V. Astin Measurement Science Award from the Department of Commerce, the Kilby International Award by the Kilby Awards Foundation, and an IR-100 Industrial Research and Development Award for his work.
Jurron Bradley is the Director of Consulting at Lux Research, leading the consulting team. Before leading the consulting team, Jurron managed the Lux Nanomaterials Intelligence service. He speaks frequently at nanotechnology conferences and has both written and led the development of nanomaterials research including major studies and weekly Journals. Before joining Lux Research, Jurron worked at Praxair, Inc., where he designed air separation and argon recycle plants and managed a thermodynamics lab. He also led and patented research efforts to reduce mercury emissions from coal-fired boilers and worked on the development of technology to reduce nitrous oxide emissions from coal-fired boilers. He later joined Praxair’s technology planning and strategy group where he worked with the Chief Technology Officer to develop strategic efforts for the entire research and development organization. Jurron received his bachelor’s degree in chemical engineering from Vanderbilt University and his doctorate in chemical engineering from the Georgia Institute of Technology, where he quantified the consolidation process of fiber-reinforced polymer composites.
Kelly Carnes is an entrepreneur, and nationally recognized technology policy expert and thought leader. She has served the high tech industry for over 20 years, holding leadership positions in technology business, law and government. She is President and CEO of TechVision21, a Washington, DC-based technology strategy firm. TechVision21 leverages technology, business and government expertise to help companies: pinpoint and secure research and technology funding; forge critical alliances with business and government leaders; and promote and protect their interests in Washington. TechVision21 clients include global companies, leading U.S. research universities, government, and science and technology non-profit organizations. Before founding TechVision21, Ms. Carnes served eight years at the highest levels of the U.S. government, working first as an aide to then First Lady Hillary Clinton, and later, as a senior technology policy advisor to four Secretaries of Commerce. Most recently, Ms. Carnes served four years as Assistant Secretary of Commerce for Technology Policy. As a Presidential appointee, confirmed by the U.S. Senate, Ms. Carnes represented the Administration before Congress, and was a liaison to, and advocate for, the technology business community. Ms. Carnes also represented the United States in negotiations with foreign governments, and in multi-lateral fora, including the Organization for Economic Cooperation and Development. Ms. Carnes also provided strategic direction and management oversight for a large Federal agency; spearheaded sophisticated, highly-leveraged public-private partnerships to promote technological innovation; and led numerous Presidential and Cabinet-level technology initiatives. Private sector partners—including Warner Brothers, Scientific American, the National Association of Manufacturers, and DeVry University—invested $50+ for every Federal dollar invested in these ventures. Ms. Carnes served as a key point person on numerous high profile issues affecting technology businesses, including regulation of E-commerce, H-1(b) visas, the R&D tax credit, securities litigation reform, financial accounting standards, and the high tech work force shortage. She also helped lead the Administration’s efforts to increase the representation of women and minorities in the nation’s technology work force. Ms. Carnes directed several Presidential-level technology programs and initiatives, including the National Medal of Technology, America’s highest award for technological innovation. She also created GetTech, an award winning national public awareness and information campaign to encourage teens to pursue technology careers. GetTech features celebrity endorsements, radio and television public service announcements, and an interactive web site. GetTech ads have been broadcast more than 45,000 times, and have reached students in 14,000 public middle schools. Ms. Carnes is known as a dynamic speaker and forceful advocate for industry on technology and competitiveness issues. She is a frequent keynote speaker at technology and business conferences around the nation, and has been widely quoted in the media, including The Wall Street Journal, The New York Times, The Washington Post, USA Today, CNN.com, Business Week.com, Information Week, CIO Magazine and The National Journal. She has been a featured guest on National Public Radio’s Talk of the Nation, and appeared on television and radio broadcasts nationwide. Ms. Carnes has served on numerous Boards and Commissions, including the Comptroller General’s Advisory Board (Government Accountability Office), the Senior Advisory Group for the Director of National Intelligence, a National Governors’ Association Commission on Technology and Adult Education, and the Steering Committee for the Commission on the Advancement of Women and Minorities in Science, Engineering and Technology (the “Morella Commission”). Ms. Carnes also has served as an advisor to the Center for Strategic and International Studies, and BEST: Building Engineering and Science Talent. In 2000, Ms. Carnes was selected by the Center for the Study of the Presidency to join an elite group of experts making recommendations to President Bush on improving the federal government’s ability to develop technology and competitiveness policy. Ms. Carnes previously enjoyed a highly successful technology business career. As an attorney at a top national law firm, Ms. Carnes structured and negotiated more than $1 billion in technology business transactions. These included joint ventures and strategic alliances, venture capital transactions, technology development, licensing and marketing agreements, systems integration projects, and large-scale computer outsourcing transactions. Ms. Carnes graduated Phi Beta Kappa from the University of North Carolina at Chapel Hill, with a Bachelor of Arts degree. She also graduated magna cum laude from Georgetown University Law School, where she served as Topics Editor for the Georgetown Law Journal.
Michael Shapiro joined the Office of Water as the Deputy Assistant Administrator in November 2002. Prior to that, he was the Principal Deputy Assistant Administrator for the Office of Solid Waste and Emergency Response (OSWER). He has been in that position since February 1997, with a brief nine months as Acting Assistant Administrator during the transition between Administrations. Before that Mr. Shapiro was the Director of the Office of Solid Waste, where he had served since November 1993. Prior to that, Mr. Shapiro served first as Deputy Assistant Administrator and then as Acting Assistant Administrator in EPA’s Office of Air and Radiation, where he directed implementation of the 1990 Clean Air Act Amendments. From 1980 to 1989, Mr. Shapiro held a variety of positions in the Office of Pesticides and Toxic Substances, where one of his responsibilities was developing EPA’s Toxic Release Inventory. Mr. Shapiro has a B.S. in Mechanical Engineering from Lehigh and a Ph.D. in Environmental Engineering from Harvard. He has also taught in the public policy program at the John F. Kennedy School of Government.
Ralph Eberts is currently serving as the Executive Managing Director of Client Accounts for Black & Veatch’s global water business. His main responsibilities include management and sales of the company’s core water business in the Americas, United Kingdom and Asia Pacific. Eberts and his team develop and maintain client relationships, manage the portfolio of projects that Black & Veatch executes for key clients, and lead client-facing activities. Prior to assuming this role, Eberts was the Managing Director for Black & Veatch’s Asia-Pacific water business where he was responsible for overseeing a business that spanned 12 offices in six countries. During his tenure he successfully managed Black & Veatch’s re-entry into the Australia water market. He played a significant role in ensuring the successful execution of the Bundamba Advanced Water Treatment Plant. The plant was an integral part of the $ 2.2 billion Western Corridor Recycled Water Project in SE Queensland, Australia which received numerous accolades and awards from the global and regional engineering community, including, in November 2009, being named as one of the Top Ten Engineering Wonders in Queensland. Through his long association with Black & Veatch Eberts has held a number of important leadership positions that include Director of Project Services and Deputy Director of Client Services for Black & Veatch’s water business in the Western United States. His project management experiences includes an important role on the full secondary expansion of the City of Los Angeles Hyperion Treatment Plant, a 15-year, $1.1 billion wastewater treatment and reclamation project, which was named one of the ten most outstanding public works projects of the 20th century by the American Public Works Association. Through these experiences Eberts has been able to provide important insight into the global and Asia Pacific water industry and has been interviewed by international and local media to provide comment about developments and trends in the industry. Eberts has been an active member of the Water Environment Federation, American Water Works Association, American Public Works Association, Structural Engineering Association of California and an officer of the Institute for the Advancement of Engineering - College of Fellows.
William Moffitt became President, Chief Executive Officer and a director of Nanosphere, Inc. in July 2004. Nanosphere (NSPH) is developing and commercializing a nanotechnology-based molecular diagnostics platform for earlier detection of disease and economical decentralization of complex genetic testing. Mr. Moffitt has 35 years of experience in the diagnostics and medical device industry, and has spent the last 20 years developing novel technologies into products and solutions that have helped shape the industry. Prior to joining Nanosphere, he served as president and CEO of i-STAT Corporation, a developer, manufacturer and marketer of diagnostic products that pioneered the point-of-care blood analysis market. Mr. Moffitt led i-STAT from its early research stage to commercialization and through its initial public offering in 1992 to its acquisition by Abbott Laboratories in 2003. Prior to i-STAT, Mr. Moffitt held increasingly responsible executive positions from 1973 through 1989 with Baxter Healthcare Corporation, a manufacturer and distributor of health care products, and American Hospital Supply Corporation, a diversified manufacturer and distributor of health care products, which Baxter acquired in 1985. Mr. Moffitt is also on the boards of three private companies and is a director and member of the executive committee of the Illinois Biotechnology Association (“iBIO”) where he also serves as an entrepreneurial coach for start-up companies. He earned a B.S. in Zoology from Duke University.
Mr. Jamison is Chairman and Chief Executive Officer and a Managing Director of Harris & Harris Group, Inc., a publicly traded venture capital company listed on the Nasdaq Global Market (NASDAQ: TINY). Harris & Harris Group focuses solely in making initial investments in “tiny” technologies, which it defines as nanotechnology and microsystems. He has previously held the positions of President, Chief Operating Officer and Chief Financial Officer of Harris & Harris Group, Inc. He is also currently Chairman and Chief Executive Officer of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of Harris & Harris Group. He is a member of the Board of Directors of Ancora Pharmaceuticals, Inc., and a Board observer in Mersana Therapeutics, Inc., Solazyme, Inc., Nextreme Thermal Solutions, Inc., and Metabolon, Inc., privately held nanotechnology-enabled portfolio companies of Harris & Harris Group. He is Co-Editor-in-Chief of “Nanotechnology Law & Business.” He is Co-Chair of the Advisory Board, Converging Technology Bar Association, a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board, and a member of the Advisory Board, Massachusetts Technology Collaborative Nanotechnology Venture Forum. Prior to joining Harris & Harris Group, he was a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property in physics, chemistry and the engineering sciences. He is a graduate of Dartmouth College (B.A., 1992) and the University of Utah (M.S., 1999).
Prior to becoming the Executive Director of the NanoBusiness Alliance, he was the Executive Director and a founding board member of AtomWorks, an initiative formed to foster nanotechnology in Illinois and more broadly throughout the Midwest. Sean has established himself as a leading thinker in the areas of nanotechnology commercialization and economic development. He has delivered keynote speeches on the commercialization of nanotechnology at several nanotechnology conferences, and served as co-chair for the commercialization focused NanoCommerce 2003 conference and trade show. Sean has been quoted extensively on the subject in many leading publications including Fortune, The Economist, the Chicago Tribune, the Chicago Sun-Times, and Small Times. Sean has been very active in nanotechnology trade and economic development issues. He helped to organize and execute the first Nanotechnology Trade Mission to Europe in conjunction with the NanoBusiness Alliance and the U.S. Department of Commerce. He has also been engaged with senior officials of the U.S. Department of Commerce’s Technology Administration on the potential impact of export control issues on nanotechnology development and commercialization. Prior to founding AtomWorks and serving as the Executive Director of the NanoBusiness Alliance, Sean had more than 7 years experience in management consulting, most recently as Engagement Manager at McKinsey & Company. Sean served a variety of Fortune 500 companies, focusing primarily upon the industrial and chemicals sectors. While there, he developed some of the firm’s early perspective on the business opportunities created by the nanotech revolution, publishing the first two internal documents on the subject. Sean received his Masters in Business Administration and Masters in Engineering Management from Northwestern University. He holds a BA in Economics from the University of Notre Dame.
Bill is VP, Innovation, Americas for Veolia Environnement. Prior to assuming his role at Veolia, Bill was the Managing Director of Cleantech Group’s Advisory Services, which assist clients in public and private sectors accelerate their implementation of cleantech solutions. Bill an internationally recognized sustainability expert, helping organizations assess and adopt technologies and practices to minimize their impact on the environment for over 20 years. He has extensive experience in climate change, environmental control technologies, information/communication technologies, new venture development, and organizational governance as well as in the energy, natural resources, chemical, electronics, and consumer products sectors. A lifelong intra- and entrepreneur, Bill has worked with clients to create new cleantech ventures and with investors to assess cleantech opportunities. He has served as an advisor to organizations including the Romanian, Italian, Mexican, Brazilian, and U.S. governments, UNIDO, the Sustainable Performance Group Investment Fund, PROPEL Board of Directors, The Conference Board, The Pew Center on Global Climate Change, The Institute of the Americas, and World Resources Institute. Bill was an environment, health and safety consulting director at Arthur D. Little, Inc. where he worked for 15 years with over 100 clients across all sectors on 5 continents in 4 languages (English, Spanish, Portuguese, Italian). Bill has a Ph.D. in Engineering and Public Policy from Carnegie Mellon and BSE in Chemical Engineering from Princeton.
Mr. Caprio www.vincentcaprio.org is the Executive Director of the NanoBusiness Alliance. Mr. Caprio www.nanobusiness.org sits on the Alliance’s Board of Directors, as well as the Board of Directors of the Emerging Industries Alliance of New York State. In November 2008, Mr. Caprio co-founded The Water Innovations Alliance www.waterinnovations.org with Mark Modzelewski. Mr. Caprio is one of the foremost advocates for government funding of emerging technologies at both the State and Federal levels. Mr. Caprio has testified before the state legislatures of New York and Connecticut, and has participated in the NanoBusiness Alliance’s public policy tour of Washington, D.C. for the past eight years. Mr. Caprio is the founder and event director of the 8th Annual NanoBusiness Alliance Conference www.nanobusiness2009.com which was held in Chicago, IL September 8-10, 2009. During the past four years (2006-2009), Mr. Caprio was an invited speaker and guest lecturer on Nanotechnology at, NanoBusiness Alliance Conferences, New York State Investors Conference 2007& 2008, University of Pennsylvania, PMI, Chemical Week 2007 & 2009, RPI, Always-On Going Green, IMAPS-New England, New York Photonics & RRPC, Commercialization of NanoMaterials 2007, The Food and Drug Law Institute, The Nanotechnology Institute-Philadelphia 2008 & 2009, Empire State Pension Conference, Pharma MedDevice, Livingston Nanotechnology Conference 2005, 2006, 2007, 2008 & 2009, Quantum Dots 2006 & 2007, 2008 MAC and The Water Innovations Conference www.waterinnovations.org In addition, Mr. Caprio has appeared on numerous Connecticut TV and radio stations discussing the impact of Water and Nanotechnology. Mr. Caprio is a 20-year publishing and tradeshow industry veteran with an impressive track record of launching events focusing on emerging technology markets. Mr. Caprio joined the NanoBusiness Alliance Conference as the founder and event director in 2002, to steer the launch of the highly successful NanoBusiness Alliance event series www.nanobusiness2009.com and www.nanoenergysummit.org in 2008 & 2009. In 2003 & 2004, Mr. Caprio served as the event director in the launch of The Emerging Technologies Conference in association with MIT’s Technology Review Magazine. Mr. Caprio has served as a consultant to the leading emerging technology research and advisory firm Lux Research, for its Lux Executive Summit in 2005 & 2006. In 2002, Mr. Caprio served as the Event Director and Program Director of the Forbes/IBM Executive Summit. Prior to joining the NanoBusiness Alliance, Mr. Caprio was event director for Red Herring Conferences, producing the company’s Venture Market conferences and Annual Summit reporting to Red Herring Magazine founder and publisher Tony Perkins. His industry peers have formally recognized Mr. Caprio on several occasions for his talents in both tradeshow management and sales. Mr. Caprio was named Sales Executive of the Year in 1994, while with Reed Exhibitions. Mr. Caprio, while employed with Reed Exhibitions, was honored with two Pathfinder Awards in 1995 for launching the New York Restaurant Show. In 2009, Mr. Caprio was nominated for the sixth straight year for the prestigious Show Manager of the Year award. Mr. Caprio graduated from Villanova University in 1979 with a B.S in Accounting and completed a MBA from Northeastern in 1987. Mr. Caprio is a member of Villanova University’s Financial Club and serves as an active member of Villanova’s President Club. Mr. Caprio serves on the Board of Trustees for the Easton Community Center in Easton, CT. In the summer of 2008, Mr. Caprio was appointed to the Board of Directors for the Fabricators & Manufactures Association Communications, Inc. based in Rockford, IL.
David J. Arthur has 30 years experience commercializing products utilizing advanced materials, including work at Rogers Corporation, A.T. Cross, TPI Composites, Helix Technologies, and Eikos. He holds a bachelor of science degree in chemical engineering from Tufts University, master of science degree in chemical engineering from the University of Connecticut and a master of business administration degree from Northeastern University. In 2005, Arthur co-founded Chasm Technologies, a consulting firm that helps its clients commercialize new products through smart application of materials science and process technology. For the past four years, he has been CEO of SouthWest NanoTechnologies (SWeNT), a leading producer of specialty carbon nanotube materials for coatings and composites applications.
Ron Durando is a long time, successful entrepreneur. He has a background in both engineering and corporate finance. Ron has been Chief Operating Officer of Microphase since 1994. When he joined Microphase, he worked with founder Ned Ergul to revive the corporation and adjust both its mission and operating style to accommodate changes in the market. He was instrumental in turning around the company and has doubled its revenues during his tour as Chief Operating Officer. Ron started and successfully ran an RF Contract Manufacturing based in China in from August 1996 until December 2008. The company grew from 6 employees operating in 6500 sq feet to over 1000 employees at it’s peek in a 150,000 square foot facility. In October 1996 he founded mPhase Technologies, Inc. He has been its President and Chief Executive Officer since the company's inception. Under Ron’s leadership mPhase produced and sold a very successful line of DSL components and he has now completed the transition of mPhase into a battery technology company that is now developing an innovative battery technology based upon breakthroughs in Microfludics and Nanotechnology.
Glenn E. Killoren is a partner in Barnes & Thornburg LLP’s Elkhart, Indiana office, where he is a member of the firm’s Business Department and co-chairman of the firm's Nanotechnology Group. Mr. Killoren concentrates his practice on general corporate matters including mergers and acquisitions, corporate finance, succession and tax planning, among other areas. He also has experience counseling clients on estate planning and commercial real estate matters, as well as considerable experience working in the recreational vehicle industry. He counsels RV manufacturers on a variety of issues including dealer financing, intellectual property, regulatory compliance, warranty claims and product liability. He was selected for inclusion in The Best Lawyers in America® 2011 in the field of corporate governance and compliance law. In his work with the nanotechnology industry, Mr. Killoren is active in the University of Notre Dame’s Innovation Park (technology commercialization), Irish Angels (venture capital) and the Nanotechnology-Business Alliance of Chicago. Mr. Killoren earned his B.B.A. in accounting in 1980 from the University of Notre Dame and his J.D. in 1983 from the Notre Dame Law School. In addition to his legal work, Mr. Killoren is an active community volunteer, serving on the boards of a community hospital, a public television station, and the Executive Committee for a not-for-profit psychiatric center. Because of his past community service efforts, he received 1st Source Bank’s Ernestine M. Raclin Community Leadership Award. Mr. Killoren is a member of the Indiana State, Illinois State and Michigan State bar associations. He also serves on the legal committee of the Recreation Vehicle Industry Association (RVIA).
Lynn L. Bergeson is Managing Director of Bergeson & Campbell, P.C. (B&C), a Washington, D.C. law firm concentrating on conventional and engineered nanoscale chemical, pesticide, and other specialty chemical product regulation and approval matters, domestic and foreign chemical classification, chemical product litigation, and associated business issues. Ms. Bergeson is also President of The Acta Group, L.L.C. and The Acta Group EU, Ltd, B&C’s consulting affiliates, with offices in Washington, D.C. and Manchester, U.K., respectively. Ms. Bergeson counsels clients on health, safety, science policy, and related legal and regulatory aspects of traditional domestic chemical regulatory programs under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) and the Toxic Substances Control Act (TSCA), as well as on issues pertinent to nanotechnology and other emerging transformative technologies. Ms. Bergeson serves on the President’s Council of Advisors on Science and Technology (PCAST) Nanotechnology Technical Advisory Group (PCAST nTAG), and served on the U.S. Environmental Protection Agency’s (EPA) Steering Committee for the Pollution Prevention through Nanotechnology Conference. Ms. Bergeson served in 2004 and 2005 on the American National Standards Institute (ANSI) Nanotechnology Standards Panel (NSP) Steering Committee and is now a member of the ISO Technical Committee 229 on Nanotechnologies. Ms. Bergeson also serves on the Board of Directors of Earth Day Network and is a member of its Executive Committee. She serves on the Board of the Converging Technologies Bar Association (CTBA) and is Chair of the CTBA Environmental, Health, and Safety Committee. Ms. Bergeson was Chair of the American Bar Association (ABA) Section of Environment, Energy, and Resources (SEER) (2005-2006), is the past Chair of the SEER Pesticides, Chemical Regulation, and Right-to-Know Committee (PCRRTKC) (2006-2008), and is now Vice Chair of the PCRRTKC, and serves in other ABA leadership positions. Ms. Bergeson is also a member of the ALI-ABA Environmental Law Advisory Panel.
Mostafa Analoui, Ph.D., is Head of Healthcare and Life Sciences at The Livingston Group (New York, NY) and Chairman and CEO of Cense Biosciences, Inc. Previously he was the Senior Director at Pfizer Global Research and Development. He is also adjunct Professor of Oral Pathology, Medicine and Radiology at Indiana University. Dr. Analoui is actively involved in investment, management and scientific/business development of nanotechnology, drug discovery/development, diagnostic imaging, and global strategies. While at Pfizer, he was the Site Head for Global Clinical Technology in Groton and New London, a division focusing on emerging technologies for development and validation of biomarkers and diagnostics for drug development. Prior to joining Pfizer, Dr. Analoui was the Director of Oral and Maxillofacial Imaging Research, Associate Professor of Radiology at Indiana University, and Associate Professor of Biomedical Engineering and Electrical & Comp Engineering at Purdue University. He was also President and CEO of Therametric Technology Inc. He has received his Ph.D. from Purdue University, followed by Post-Doctoral Fellowship at IBM TJ Watson Research Center in NY. In addition to industry leadership in biomedical and technology fields, he consults and lectures in US, Europe and Asia. He has also served on various scientific, regulatory, and business advisory committees and boards, including NIH, NSF, PhRMA, NASA, and OECD. Dr. Analoui has authored over 130 publications, including journal articles, book chapters and technical reports. He is senior member of IEEE, SPIE, and RSNA. He currently serves as board member of VirtualScopics (Nasdaq: VSCP), Calando Pharmaceutical (Nasdaq: ARWR), BEACON (Biomedical Engineering Alliance and Consortium) and NanoBusiness Alliance.
Mr. Rung is a senior high technology R&D executive with over 25 years of R&D management experience in CMOS process technology, application-specific integrated circuit (ASIC) design and electronic design automation (EDA), IC packaging, MEMS, microfluidics, and inkjet printing. Shortly after retiring in 2001 as the director of Advanced Research and Development at Hewlett-Packard’s Corvallis, OR inkjet technology headquarters, Mr. Rung was asked to start up the Oregon Nanoscience and Microtechnologies Institute (ONAMI), Oregon’s first “Signature Research Center” and an unprecedented collaboration among Oregon’s research universities and the Pacific Northwest National Laboratory. ONAMI’s dual mission is to grow “small tech” research in Oregon and commercialize technology in order to extend the success of Oregon’s world-leading “Silicon Forest” technology cluster, which includes the most advanced R&D and manufacturing operations for leading companies such as Intel Corporation, Hewlett-Packard Company, FEI Company, Invitrogen/Life Technologies, Flir, Precision Castparts, Electro Scientific Industries, Planar Systems, Xerox Office Products, Tektronix, ON Semiconductor and many dynamic smaller firms. ONAMI has so far received $42M in state investment and approximately quadrupled Oregon’s annual federal and private research awards in the fields of nanolaminates and transparent/printed electronics, green nanotechnology, nanoscale metrology, and microtechnology-based energy and chemical systems (MECS). The ONAMI gap fund has helped launch or enable 14 spinoff or startup companies since late 2006.
Curt W. Hidde is a partner in the Business Department of the Indianapolis, Indiana office of Barnes & Thornburg LLP, and a member of the firm’s Nanotechnology, Private Equity and Entrepreneurial Services Practice Groups. Mr. Hidde’s primary areas of practice include securities law, corporate finance, private equity, general corporate, and mergers and acquisitions. Mr. Hidde devotes a substantial part of his practice to advising early-stage and fast-growing companies on the numerous legal issues they face, including developing their capital structure and securing angel and venture capital investments, as well as advising them on exit strategies, including private sales, IPOs, and recapitalizations. Mr. Hidde also represents public companies in a wide variety of matters, including periodic reporting and compliance under the Securities Exchange Act of 1934, public and private offerings of securities (including IPOs and secondary offerings), tender offers and takeover offers, mergers and acquisitions, recapitalizations, and going private transactions. Mr. Hidde’s clients include life sciences companies, technology and software companies, retail and consumer products companies, traditional manufacturing and distribution companies and financial services companies. Mr. Hidde serves on the Board of Directors and Executive Committee of the Venture Club of Indiana, a non-profit, volunteer led organization focused on creating an entrepreneurial, business-friendly environment in Indiana to serve as a catalyst for increased investing in Indiana businesses. He also serves as an Advisory Board member for the Central Indiana Small Business Development Center. He received his B.A. from Indiana University and received his law degree from the University of Dayton School of Law. Mr. Hidde is a frequent speaker on securities, business, private equity and venture capital issues.
James M. Hussey joined NanoInk, as Chief Executive Officer and member of the Board of Directors, in January 2008. Mr. Hussey brings 25 years of experience in the pharmaceutical and biotechnology industry as executive, founder, investor and consultant to senior management and boards of directors. Prior to joining NanoInk, Mr. Hussey was with Ovation Pharmaceuticals, where he was a member of the senior operating committee, serving as Head of Alliances and Vice President of Corporate Development. He was President and CEO of NeoPharm, Inc., as well as a member of the Board of Directors and an investor/shareholder. In 1994, he founded Physicians Quality Care, a health care services IPA Management Company, which was sold to a public company in 1998. Prior to founding Physicians Quality Care, he was with Bristol Myers Squibb in Princeton, New Jersey, serving as General Manager as well as other positions in marketing, new business development and sales. Mr. Hussey holds a B.S. in Pharmacy from Butler University, Indianapolis, Indiana, and an M.B.A. from University of Illinois at Chicago.
Todd G. Vare is a partner in the Intellectual Property Department of Barnes & Thornburg LLP, where he concentrates his practice in the litigation of patent disputes and counseling on the protection of intellectual property assets. Mr. Vare has litigated patent disputes covering a wide variety of technologies, including gene sequencing, pharmaceuticals, medical devices, telecommunications, software programs and processes, cellular antenna systems, and mechanical devices. Mr. Vare also has litigated a variety of other intellectual property and business disputes in state and federal courts involving trade secrets, copyright, software performance, software licenses, employee non-compete and non-disclosure agreements, and rights of publicity. He is a frequent speaker on trial and litigation techniques, multi-media trial presentation strategies, and electronic discovery. In addition to trial work, Mr. Vare has significant federal and state appellate court experience. He has represented clients in appeals before the 7th Circuit, the Federal Circuit, and the 11th Circuit. Mr. Vare also argued before the United States Supreme Court in U.S. v. Santos, which resulted in a victory for his client involving the scope of the federal money laundering statute. Mr. Vare is co-chairman of the firm's Nanotechnology Group and Business and Technology (BTech) Group. He also is an active member of the firm's Life Sciences Group. In these roles, Mr. Vare counsels clients on a variety of matters along the pathway of "concept to commercialization" in the life sciences and technology industries, as well as the application of nanotechnology to these and other industry sectors. His client counseling includes IP protection, computer and software protection, e-commerce processes, electronic signatures, Internet security, and other business technology matters. Mr. Vare is on the Advisory Board for Nanotechnology Law & Business, a journal for attorneys, entrepreneurs, and investors involved in small scale technologies. Mr. Vare is admitted to practice in Indiana and Illinois, the U.S. Supreme Court, the U.S. Courts of Appeals for the Federal Circuit, the 7th Circuit, the 11th Circuit, and the U.S. District Courts for the Northern District of Illinois, Southern District of Indiana, and Northern District of Indiana. Mr. Vare devotes a considerable portion of his time to pro bono matters and regularly accepts appointments under the Criminal Justice Act from the 7th Circuit Court of Appeals. Mr. Vare received his J.D. summa cum laude from Indiana University School of Law - Indianapolis in 1994. He graduated from Miami University in 1987 with a B.A. in international studies in 1987. He also received an M.B.A. from the Indiana University School of Business in 1989, and worked in marketing communications before attending law school.
Jon Belkowitz is the President and Owner of B & B Premier Concrete, LLC specializing in the Research, Development and Education with a focus on Nanotechnology. Before forming B & B, he served in the United States Air Force from 1996 to 2006 specializing in Civil Engineering. His tour of duty introduced Mr. Belkowitz to a wide variety of concrete types and uses dependent on engineering practices of different host nation forces, developing nations, and disaster repair initiatives. Jon has worked in private testing laboratories on structural engineering proposals and materials development projects to include the application of nanotechnology in concrete. Mr. Belkowitz has worked as a consultant on projects in the United States, India, Turkey, Africa, Italy, and Germany. From 2006 to 2010 he served as the Research and Development Supervisor for Lafarge's Western United States business units. As the supervisor he developed, implemented, and managed research and development projects for the Chronolia and Extensia product lines. In 2008, his Chronolia Road Patch Design received the "Innovation of the Year Award" from the American Concrete Institute - Rocky Mountain Chapter. Mr. Belkowitz graduated with distinction from Colorado School of Mines with a B.S. in Civil Engineering and the University of Denver with a Master's of Materials Science. He has been an invited guest speaker, lecturer and panelist on nanotechnology in concrete to the Department of Defense, the offices Homeland Security and National Defense, the American Concrete Institute, the National Ready-Mixed Concrete Association, government laboratories, and officials in France, Canada, UK, and Germany. Jon is a past-chapter president of the American Concrete Institute and a member of ACI 236-D Committee, Nanotechnology in Concrete. Jon has also authored a number of articles on the use of Nanotechnology in concrete to include, "An Investigation of Nano Silica in the Cement Hydration Process." Mr. Belkowitz will present on the topic: "Nanotechnology of Concrete - Small Technology with Big Applications"
Dr. Jeff Lomprey is an associate with Foley & Lardner LLP and is a member of the firm's Chemical, Biotechnology & Pharmaceutical Practice as well as the Nanotechnology Industry Team. Dr. Lomprey's practice focuses on patent preparation, both U.S. and foreign prosecution, counseling, due diligence, and litigation support. His interests span a diverse array of chemical and mechanical technologies. Dr. Lomprey has significant experience in the areas of small molecule chemistry, pharmaceuticals, batteries, catalysts, polymers, mechanical devices, and medical devices. Dr. Lomprey earned his Juris Doctorate from the University of Wisconsin Law School (cum laude, 2005), where he was a member of the Dean's list. He earned his Ph.D. in chemistry from the University of Kentucky (1993), and was the recipient of the Outstanding Graduate Student Researcher Award. He earned his Bachelor of Science degree in chemistry from the University of Wisconsin – Stevens Point (1988). From 1997-2002, Dr. Lomprey was a senior research chemist at Gentex Corporation, where he was involved in the development and production of automatically dimming automobile mirrors. He also taught chemistry as an adjunct professor at Grand Rapids Community College. Dr. Lomprey is admitted to practice in Wisconsin and before the United States Patent and Trademark Office. He is a member the Wisconsin and American Bar Associations, the American Chemical Society and the American Intellectual Property Law Association.
Mr. Kane is the former Executive Director of the Illinois Technology Enterprise Center at Argonne National Laboratory and Entrepreneur in Residence with Illinois Ventures, LLC. As EIR, Mr. Kane was interim CEO of several of their portfolio companies. He has closed several rounds of venture capital from various sources and has secured numerous SBIR and government contracts and awards. As a consultant he has evaluated the commercial potential of advanced technologies for The University of Chicago, Argonne National Laboratory, the University of Illinois at Urbana-Champaign and the Illinois Institute of Technology. Mr. Kane was named a 2007 Technology Pioneer by the World Economic Forum. Earlier he was Regional Business Development Manager for Microsoft Corporation in Chicago. In this role he identified, negotiated and closed a $25 million equity investment in an Illinois-based software company. He spoke publicly as an evangelist for Microsoft on dozens of occasions. He began his business career at IBM where he held a series of marketing and technical positions. In his last position, he was a Business Consultant focused on furthering the technology penetration of IBM products at several major accounts in the process and consumer packaged goods industries. Before that, he was the IBM liaison to Andersen Consulting (now Accenture) and helped create the strategic business alliance between IBM and Andersen Consulting that became the model for the industry. In this capacity he earned membership into IBM’s Golden Circle. He began his career as a manufacturing engineer in IBM’s San Jose, California disk drive facility where he designed robotic tooling. Neil holds a Bachelor of Science degree in Mechanical Engineering from the University of Illinois at Urbana-Champaign (high honors) and a Masters of Business Administration (finance and policy studies) from The University of Chicago. He has attended graduate school in Australia and attended a post-graduate international management program in Japan on scholarship from JETRO.
Sven Riethmueller is a partner with Foley & Lardner LLP and is a member of the firm's Private Equity & Venture Capital, Real Estate, Transactional & Securities, International Business and Chemical, Biotechnology & Pharmaceutical Practices and the Emerging Technologies, Energy and Life Sciences/Medical Devices Industry Teams. Mr. Riethmueller counsels clients on complex business transactions, cross-border private equity and real estate investments, fund formation for foreign investors in U.S. and overseas investment opportunities, cross-border mergers and acquisitions, corporate finance matters, joint ventures and strategic alliances, IP licensing, technology transfers and collaborations, U.S. securities and stock market regulations, and compliance. Mr. Riethmueller's practice focuses on cross-border legal affairs, including representing European and other foreign funds, fund sponsors, financial institutions, and investors as well as European and other foreign electronics, software/IT, biotechnology, medical device, and other technology and consumer products companies in their investment activities and business dealings in the United States, as well as U.S. investors, funds and businesses with their overseas activities. Mr. Riethmueller travels to Europe on a regular basis where he is a speaker on a variety of issues affecting European businesses in their investment activities and business dealings within the United States. Mr. Riethmueller has broad experience in structuring investments for German and other European investors in U.S. private equity, real estate and alternative asset funds and opportunities, including developing novel investment structures. Prior to joining Foley & Lardner, Mr. Riethmueller practiced at a leading New England-based law firm focused on cross-border real estate and venture capital investments and transactions. Prior to returning to private practice, Mr. Riethmueller was vice president & general counsel to LION bioscience AG, a publicly traded (Nasdaq National Market and Frankfurt Stock Exchange) global solutions provider for the life sciences industry. In his former capacity as LION's general counsel and as a member of its senior management, Mr. Riethmueller was responsible for LION's worldwide M&A and strategic transactions, LION's compliance, worldwide software and intellectual property licensing, biotech research collaborations, U.S. employment and HR matters, U.S. litigation management, and restructuring of the company's U.S. operations. Prior to joining LION, Mr. Riethmueller practiced in the area of cross-border corporate finance and M&A in New York, London and Frankfurt with the international law firms of Sullivan & Cromwell and Cleary, Gottlieb, Steen & Hamilton, where he advised some of the largest securities and corporate finance offerings of European companies and banks. Mr. Riethmueller also practiced as a business litigator for a number of years with a leading law firm in the western United States, where he represented U.S. and foreign investors and businesses in litigation before federal and state courts. Mr. Riethmueller earned his law degree from Columbia University School of Law (J.D., 1994) and his bachelor of arts degree, summa cum laude, from Dartmouth College, where he was a member of Phi Beta Kappa. Mr. Riethmueller is admitted to practice in Massachusetts and New York and has been admitted to practice in Nevada, where he is currently on inactive status. Mr. Riethmueller was born and grew up near Bremen, Germany and practiced law for a number of years in Frankfurt and London. He is fluent in German.
J. Steven Rutt is a partner with Foley & Lardner LLP. He is vice-chairman of the Nanotechnology Industry Team and a member of the Chemical, Biotechnology & Pharmaceutical Practice. His practice includes patent counseling, IP licensing and agreements, including technology transfer carried out under the Bayh-Dole Act, patent landscaping and clearance opinions, patent prosecution, patent litigation support, trade secrets, and trademarks. His technology background is with materials and polymers, including applications in nanotechnology, cleantech, nanobio and nanomedicine, printed electronics, pharmaceuticals, semiconductors, and biotechnology. An area of focus for Dr. Rutt is coordinating the delivery of all aspects of IP legal services to emerging companies and representing them in their agreement negotiations. Dr. Rutt is a frequent writer and conference presenter with respect to nanotechnology and the law, actively helping to lead and participate in Foley's Nanotechnology Industry Team. He serves as Foley's nanotech-cleantech blog editor (www.nanocleantechblog.com). He is also actively involved in legal training programs providing CLE. In addition, he is the author of a dozen scientific publications and inventor on four patents. His experience includes nine years of hands-on research in polymer synthesis and morphological studies, and his experience in private industry includes two years of corporate chemical research with NTT in Tokyo, Japan. His recent presentations include: * "University Patenting: Why Important," University of Texas, Dallas Seminar, February 2010 * "Recent Legal Developments Relevant to Nanomedicine," American Society for Nanomedicine, October 2009 * "Counseling Clients on PCT, EPO, and ex-US Patenting," July 2009 * Panel moderator on IP Due Diligence, Houston NSTI TechConnect Conference, May 2009 * "Legal Aspects of Commercializing Technology," National Nano Engineering Conference (NNEC2008) in Boston, November 2008 * Regenerative Therapies in London, October 2008 * "Patent Counseling Including Inventorship, Ownership, Licensing, Contracts, Due Diligence, Bayh-Dole Act, and Trade Secrets," October 2008 * NSTI Nanotechnology and Cleantech Conferences in Boston, June 2008 * Panel moderator at NanoBusiness Alliance Conference on Nanotechnology in Health Care, May 2008 * Presented two separate topics at the Licensing Executive Society meeting on Quality Nanotechnology Patents and Nanotechnology Patent Licensing, May 2008 * Panel moderator between venture capitalists and an equity analyst on nanotechnology-cleantech investment, IBF Nano Applications Forum in Palm Springs, February 2008 * Roundtable moderator on patent strategy, including inputs from the Patent and Trademark Office's nanotechnology administrator and European patent counsel, February 2008 * Presented on the topic of nanotechnology IP to OnSETT (an Ontario technology transfer group) in Toronto, October 2007 * Presented on the topic of IP due diligence to an Orlando angel investor group, October 2007 * "NNI's Impact Measured in Patents," presented to the President's Counsel of Advisors on Science and Technology (PCAST), June 2007 Dr. Rutt's legal papers have been published widely. Selected recent works include: * "Global Warming U.S. Patent Filings Exploding," www.nanocleantechblog.com, May 19, 2010 * "Nanotech Continues to Fuel Cutting Edge Cleantech," www.nanocleantechblog.com, May 17, 2010 * "Biofuels Developments: Government Support Continues, Patent Activity Exploding," www.nanocleantechblog.com, May 4, 2010 * "IP Disputes and Nanotechnology Company Bankruptcies," Nanotechnology Law and Business, Vol 6, No. 3, Fall 2009 * "Review of A Consumer's Guide to MEMS & Nanotechnology," Nanotechnology Law and Business, Vol. 5, No. 1, Spring 2008 * "New Patent Rules Will Dramatically Impact Nanotechnology Patenting," Nanotechnology Law & Business, Vol. 4, No. 4, Winter 2007 * Commentary on obviousness for nanotechnology patenting after KSR published in the Journal of the Patent & Trademark Office Society * Detailed case review of the Federal Circuit's 2006 decision in Zoltek v. U.S. (on government liability for importation patent infringement), Nanotechnology Law and Business Journal, Vol. 3, Issue 4, 2006 * "Simple steps make complex patenting system manageable," invited column, Small Times * "Top Developments to Watch in Nanotechnology Law," The SciTech Lawyer, Vol. 2, Issue 3, Winter 2006 * "What Hath Congress ‘CREATEd?' New Patent Legislation, CREATE, Directed to Joint Research Agreements," Nanotechnology Law & Business Journal, Vol. 2, Issue 2, 2005 * Japan Bayh-Dole article in Legal Times, April 2005 * "From Plastics to Nanotechnology: Cambridge Display Technology's IPO Registration," Nanotechnology Law & Business Journal, Vol. 1, Issue 4, 2004 * "Technology Transfer Under Japan's Bayh-Dole: Boom or Bust Nanotechnology Opportunities," Nanotechnology Law & Business Journal, Vol. 1, Issue 3, 2004 * Book review, "Innovation and Its Discontents," Nanotechnology Law & Business Journal Vol. 2, Issue 1, 2005 Dr. Rutt received his law degree from Georgetown University Law Center in 1999. His chemistry doctorate was conferred in 1990 by The Pennsylvania State University (where he was a Braddock Fellow), and he holds a bachelor's degree in chemistry from Goshen College. Dr. Rutt is a member of the Licensing Executive Society (LES) and the Association of University Technology Managers (AUTM).
The year 2010’ marks Don’s 3rd decade as a practicing Industrial Hygienist beginning with Radiation Safety at North Dakota’s largest radioisotope laboratory. During his tenure with NDSU, Don completed his BS in Chemistry and worked towards an MS in Business Administration along with a PhD in Biochemistry. In 1985, Don founded HTI Laboratories and Industrial Consultants, an environmental engineering and consulting firm. This start-up venture gained national recognition and in 1990, the company boasted more than 100 professionals working from 5 offices nationwide. As a leading field & laboratory services organization, HTI served some of our country’s largest corporations as well as a Who’s Who of institutional, industrial, and governmental cliental. Through HTI, Don oversaw environmental sampling of the World Trade Center’s Twin Towers, remediation of medical facilities at Guantanamo Bay Cuba, creation of the first EPA-NIST Mobile Laboratory, and development of major environmental laws. Following years as an expert witness in the area of forensic toxicology, Don accepted a position as Research Scholar in the Center for Environmental Toxicology & Technology at Colorado State University and furthered his graduate work in Environmental Health and Toxicology. Upon leaving CSU, Don began work with the Fort Peck Tribes of Northeastern Montana. There, he led this tribal nation toward satisfaction of a major consent decree. Upon conclusion of this work, Don returned to Colorado where he served as the EH&S Manager for NanoProducts Corporation, a venture capitalized manufacturer of high volume nanopowders. In this position, he provided guidance to an anxious health community concerned about the toxic effects of nanoscale material exposures. More recently, Don joined OSO BioPharmaceuticals, formerly Catalent Pharma Solutions, in their New Mexico based corporate operations. With OsoBio, Don provides global EH&S management over FDA-cGMP Risk Programs and is utilizing his vast industrial hygiene and environmental experience to create leading edge Occupational Health Programs involving a wide range of potent pharmaceutical compounds. Don is also immediate Past-Chair of the American Industrial Hygiene Association’s Nanotechnology Working Group where his leadership skills continue to be used to benefit the professionals and public served by this important organization.
Anil Diwan is the president of Nanovicides, Inc. a company developing novel antiviral technologies. Located in West Haven, CT, this firm has developed a platform technology which has been shown to have excellent efficacy in laboratory studies on the viruses that lead to: HIV, herpes simplex, various forms of influenza, as well as several viral ophthalmic infections. Nanoviricides technology (licensed from TheraCour®, a privately held company founded by Dr. Diwan.) involves novel polymeric-micelles which have been under development since 1991. The technology has one issued patent, three filed international patent applications, and several additional patent applications in various stages. NanoViricides, Inc. was founded by Dr. Diwan, Dr. Seymour and others to commercialize these unique nanomedicine antiviral technologies. Dr. Diwan is a prolific inventor and a serial entrepreneur. Prior to founding NanoViricides, Inc., he has founded TheraCour Pharma, Inc., a privately held company working in nanomedicines. Additionally he founded AllExcel, Inc., a company with diverse portfolio including nanomedicines, small chemicals, device technologies, and informatics. He has won several NIH SBIR grant awards. Anil holds a Ph.D. from Rice University, TX, and a Bachelors in Technology from the Indian Institute of Technology, Bombay (IIT-B), India. He has over 18 years of bio-pharmaceutical R&D experience as well as 12 years of experience as an entrepreneur.
Dr. Piotr Grodzinski is a Director of NCI Alliance for Nanotechnology in Cancer at the National Cancer Institute in Bethesda, Maryland. He coordinates program and research activities of the Alliance which dedicated $144M over next 5 years to form interdisciplinary centers as well as fund individual research and training programs targeting nanotechnology solutions for improved prevention, detection, and therapy of cancer. Dr. Grodzinski is materials scientist by training, but like many others found bio- and nanotechnology fascinating. In mid-nineties, he left the world of semiconductor research and built a large microfluidics program at Motorola Corporate R&D in Arizona. The group made important contributions to the development of integrated microfluidics for genetic sample preparation with its work being featured in Highlights of Chemical Engineering News and Nature reviews. After his tenure at Motorola, Dr. Grodzinski was with Bioscience Division of Los Alamos National Laboratory where he served as a Group Leader and an interim Chief Scientist for DOE Center for Integrated Nanotechnologies (CINT). In his current capacity at the National Institutes of Health (NIH), he is also co-chairing Trans-NIH Nanotechnology Task Force, which is coordinating the nanotechnology efforts across 27 institutes of the agency with the budget over $200M/year. Dr. Grodzinski received Ph.D. in Materials Science from the University of Southern California, Los Angeles in 1992. He is an inventor on 15 patents and published 47 peer-reviewed papers, 7 book chapters, and delivered over 100 invited conference presentations. Dr. Grodzinski has been an invited speaker and served on the committees of numerous bio- and nano-MEMS conferences in the past years.
Ioannis Tomazos, PhD, MBA (Chief Executive Officer) Dr. Tomazos was appointed as the CEO of Biorasis Inc. in 2008. Soon after Biorasis Inc. was named as “a company to watch in New England". Dr. Tomazos received a Doctoral degree in Cellular Biology and a Masters in Business Administration (MBA) in marketing from the University of Connecticut (UCONN). In the school of business he worked as a consultant for three businesses in the State of Connecticut, as a research assistant at the Office of Technology Commercialization of UCONN and completed an internship at Well Point.
Dr. Rangaramanujam. M. Kannan is a professor of chemical engineering and materials science, and biomedical engineering at Wayne State University, Detroit, Michigan. He obtained his PhD from the California Institute of Technology (1994), and a post-doc from the University of Minnesota. After a two-year stint at 3M Corporate Research, he joined the Wayne State faculty. His research spans a wide range of nanomaterial applications, including nanomedicine and nanocomposites. He has initiated an interdisciplinary translational research program based on dendrimers, with a specific focus on targeted drug delivery for neurodegenerative diseases such as cerebral palsy, and age-related macular degeneration. Dr. Kannan is an author of four patents, more than 60 publications. He has won several recognitions, including the NSF CAREER and Unilever awards, and serves on the editorial board of Nanomedicine (NBM). He serves as the chief technology officer of nanotech start-up nanoScience Engineering Corporation.
Sarah E. Lee, Ph.D., is a Research Scientist in Product Development (Formulation) at Baxter Healthcare Corporation (Round Lake, IL). She is involved in early-stage formulation development for new injectable products, including developing nanoparticle formulations of poorly-soluble compounds, with a focus on the principles of interfacial surface interactions for colloidal stabilization. She has expertise in analytical biochemistry, where she has driven impurity identification and quantification efforts for complex biomolecular therapeutics. She also participates in manufacturing troubleshooting, focusing on assay implementation in manufacturing plants. Her other research areas include preclinical development of sustained-release injectable drugs and dosage form design. Dr. Lee earned her Ph.D. in organic chemistry from the University of Wisconsin-Madison in 2006 and has authored several publications and patents.
Michael Lefenfeld, a serial inventor, founded SiGNa Chemistry in late 2004 based on a green process that stabilizes reactive metals. This technology enables companies to safely harness the legendary powers of reactive metals. As President and CEO of SiGNa, Mr. Lefenfeld is applying his science and materials expertise to drive the adoption of these advanced materials into the mainstream of chemical reactivity and hydrogen fuel markets. SiGNa has been awarded the 2008 Presidential Green Chemistry Award along with the World Economic Forum's Technology Pioneer Award. Prior to SiGNa, Mr. Lefenfeld independently commercialized several biomedical and chemical technologies. Additionally, he has been employed as a Member of the Technical Staff at Bell Laboratories and a researcher at DuPont. In addition to over 20 scientific publications, he holds numerous patents and patent applications in areas ranging from controlled release to organic electronics to chemical reactivity. In 2005, Mr. Lefenfeld was featured on the cover of Red Herring as Top Researcher, and was named one of BusinessWeek's Top Entrepreneurs Under 25, Red Herring's Top 25 Entrepreneurs Under 35, and Inc. Magazine's Top 30 Entrepreneurs Under 30. Mr. Lefenfeld earned his B.S. in Chemical Engineering and Physics at Washington University in St. Louis and a S.M. and M.Phil. in Chemistry at Columbia University.
Paul Stimers focuses his lobbying efforts on matters related to nanotechnology, information technology policy, and defense, and advises a wide range of companies and industry associations in pursuing legislation and representing their interests before Congress and Federal agencies. Paul represents the NanoBusiness Alliance, the nanotechnology industry association, in developing and advocating for policies that will expand the nation’s nanotechnology infrastructure. He coordinates the Alliance’s annual Policy Tour, which brings dozens of nanotechnology leaders to the capital for meetings with senior government officials. He also works with several of the world’s leading nanotechnology companies to secure federal funding for research and development projects. In the field of information technology policy, Paul works with software companies and industry associations to ensure data and network security without restricting technological development. He also advises the Alliance for Digital Progress – a coalition of technology companies, consumer groups, and public–interest organizations – in its efforts to prevent technology mandates. Paul has significant knowledge of and experience in defense and homeland security issues. He represents a number of companies working with the Department of Defense in the areas of RDT&E and procurement. Working with Water Advocates, a non–profit organization raising awareness of the need for safe drinking water and sanitation worldwide, Paul helped to pass the Water for the Poor Act of 2005, which for the first time commits the United States to making water development a major foreign policy goal. Paul was senior editor of the Journal of Law and Public Policy at Harvard Law School. While attending Harvard’s Kennedy School of Government, Paul was a charter member of the Harvard Association for Law and Policy and a member of the Council for Emerging National Security Affairs. At the Kennedy School, Paul specialized in national security, focusing on terrorism, weapons of mass destruction and defense planning. Before coming to K&L Gates, Paul worked as an intern with Representative George Nethercutt (R–WA) and for the Department of the Navy.
Mike Pellegrino, expert intellectual property valuation analyst and company president. Mike Pellegrino is the founder and President of Pellegrino & Associates. He is a former practicing software engineer, chief finance officer, and accountant. This diverse background gives Mike the requisite experience to credibly and defensively value intellectual properties that include best-selling books, top-selling branded products, cutting-edge software, patents that drive many of today's high-tech products, and even John Dillinger's publicity rights. An unconventional valuation analyst, Mike plays no favorites when it comes to valuation. With a strong emphasis on the economic fundamentals of the assets he values, he has developed a reputation for asking penetrating questions that can get right to the heart of an asset's value. Mike has successfully defended his value opinions in state and federal court actions as well as with state and local tax authorities and the Internal Revenue Service. Mike is a prolific writer, authoring more than two dozen articles on technology and intellectual property valuation as well as the book BVR's Guide to Intellectual Property Valuation. Those writings have called into question some of the most basic valuation theories that many practitioners have followed blindly for years. Yet, from those writings, Mike has developed new methods to aid IP valuation, helping valuation analysts assess risk and quantify discount rates, select proper valuation methods, and perform necessary due diligence. Mike is also an energetic and frequent speaker on software and intellectual property valuation, delivering practical seminars and bootcamps regularly that integrate many valuation examples drawn right from the headlines. In addition to being a regular speaker for Business Valuation Resources and Purdue University, Mike was a 2009 keynote speaker on intellectual property valuation for the 2009 National Innovation Conference & Exhibition at Kuala Lumpur, Malaysia. Mike has the distinction of bringing two separate issues to the Indiana legislature that are now memorialized into state law. One issue focused on embedded software valuation and the other issue focused on the tax treatment of patent income. In both cases, Mike helped author the statutes, provided material testimony to the legislature and worked with the governor's office to frame the legislation, which Indiana Governor Mitch Daniels ultimately signed into law. In both cases, Mike helped Indiana's Legislative Services Agency, which performs fiscal analysis of the legislation, evaluate the economic impacts of his ideas on the state economy. Mike authored the administrative rules that Indiana's Department of Local Government and Finance now uses to administer the evaluation of software appraisals for property tax matters. Mike graduated from the Indiana Tech summa cum laude with a Bachelor of Science degree in computer science, earned a Master of Business Administration degree from Ball State University, went back to school a third time for accounting at Indiana Tech, and attended the Center for Creative Leadership's flagship Leadership Development Program. Mike serves on the board of the Indiana Venture Club and The Villages. Mike is a former board member of Techpoint, the Techpoint PAC, Early Childhood Alliance (Executive Secretary), and Pathways, a not-for-profit organization that helps runaway teens Mike is married and resides in Indianapolis, Indiana. He enjoys fast recreational bicycling, playing both electric and acoustic guitar, sailing, traveling internationally, and working on self-improvement.
Winton G. Gibbons joined Nanosphere midyear 2007 as Senior Vice President of Business Development. From 2005 to 2007, he was Senior Vice President for Strategic and Global Product Marketing at Biosite (now Inverness Medical). For the period of 1997 through 2005, he was a sell-side equity analyst for the investment firm of William Blair & Company, L.L.C., covering diagnostic, life science and biotech biotechnology companies, and during which he became a Principal, as well as Group Head for healthcare. Prior to that position, from 1994 to 1997, Mr. Gibbons was Vice President of Strategy and Business Development for the Patient Care Division of Boehringer Mannheim Diagnostics (now Roche Diagnostics). He has also been a Director of Management Services at Merck & Co., a consultant and manager at McKinsey & Company, and held marketing and sales positions at Conoco Chemicals, where he began his career. Mr. Gibbons holds an M.B.A. in Finance and Business Policy from the University of Chicago—Graduate School of Business and a Bachelor of Science degree in Chemistry from Duke University.
Fern is a partner in the firm's Product Liability Litigation, Business Litigation and Life Sciences practice groups. She focuses her practice on health effects litigation and regulatory matters involving product liability and toxic tort. She has litigated numerous cases involving medical and pharmaceutical products, consumer products, environmental exposures to heavy metals, chemicals, and tobacco, among others. Fern also represents emerging technology companies and research organizations, including those developing and commercializing nanotechnology-enabled products. She represented Wyeth in "fen-phen" diet drug litigation. She served as national counsel for a major bloodbank in US AIDS and hepatitis C cases. Fern regularly counsels clients on liability prevention, regulatory matters, and liability-related transactional issues, including due diligence. She also represents companies in the homeland security and biodefense areas; recently she advised a private research and university consortium in pursuing a bid for a national bioterror research laboratory. Fern is a frequent author and speaker on product liability and mass tort issues such as class actions, admissibility of expert evidence, and product liability prevention. Prior to private practice, she served as a law clerk to former Circuit Judge Kenneth W. Starr of the US Court of Appeals for the District of Columbia Circuit. Fern is admitted to practice in the District of Columbia, the commonwealth of Virginia, the United States District Court for the District of Columbia, United States District Court for the Eastern District of Virginia, United States District Court for the Western District of Virginia, United States District Court for the District of Maryland, United States Court of Appeals for the District of Columbia Circuit, District of Columbia Court of Appeals, and the United States Court of Appeals for the Fourth Circuit.
Tom is a partner in the Product Liability and Business Litigation practice groups, as well as the firm's Loss Prevention Partner. He handles a wide variety of complex civil litigation matters, including toxic tort, class actions, securities, fiduciary duty. Tom has represented the chemical industry in matters involving employee injuries and related fraud and conspiracy allegations in numerous cases across the U.S.; and in matters involving medical monitoring related to chemical exposure. He also has represented will and trust beneficiaries in disputes regarding interpretation of multiple instruments controlling disposition of multimillion dollar trust corpus; investors defrauded of multimillion dollar investments by financial advisor; and shareholders in closely held corporations against co-shareholders regarding usurpation of corporate opportunities, wasting or theft of corporate assets and other disputes. Tom is admitted to practice in Ohio, the District of Columbia, the District Court of the District of Columbia, the District Court of the Northern District of Ohio, the U.S. Supreme Court and the United States Court of Appeals for the Sixth Circuit
John S. Young, Jr., serves in the dual role as President of American Water Works Service Company and Chief Water Technology Officer of American Water. In this role, he is responsible for the business and operation functional support for the American Water utility subsidiaries, promoting innovation and technology across the business and for facilitating and managing growth opportunities within American Water. John is an active member of several professional organizations, including being the Board Chair of the Design/Build Institute of America and a Board Member of the American Water Works Association and the WateReuse Foundation John is a registered professional engineer in a number of states. He holds a B.S. in Civil Engineering from Duke University, and an M.S. in Environmental Engineering from the University of North Carolina.
Mike has served in various management roles for numerous global corporations (HP, Compaq and W.L. Gore and Associates) all in new business creation. Mike has more than 28 years of practical experience in business management, leadership, development, and sales. He has launched, developed and led over 19 new businesses ranging from automatic test equipment to medical electronics to consumer electronics to end-to-end security authentication systems to bioscience with big Pharma to the latest in board game industry. Mike’s global understanding of the business marketplace is one of the key ingredients to his success. In addition to his involvement with Zapstechnologies, Inc., Mike is the CEO of Pajaggle a early stage board game business, and the President of BTCG, Inc., a consulting firm specializing in new business development. Mike holds a bachelor’s degree in Mechanical Engineering from the University of Delaware, specializing in advanced aerodynamics. He has completed graduate courses in business strategy, business management, competitive analysis, and marketing. Mike holds board positions with several non-profit agencies including; President of the Business Enterprise Corporation (a high technology incubator), The OSU Venture Fund Advisory Committee and has been an advisory board member for three emerging high-tech firms. Mike is a holder of several patents.
Prior to becoming the Executive Director of the NanoBusiness Alliance, he was the Executive Director and a founding board member of AtomWorks, an initiative formed to foster nanotechnology in Illinois and more broadly throughout the Midwest. Sean has established himself as a leading thinker in the areas of nanotechnology commercialization and economic development. He has delivered keynote speeches on the commercialization of nanotechnology at several nanotechnology conferences, and served as co-chair for the commercialization focused NanoCommerce 2003 conference and trade show. Sean has been quoted extensively on the subject in many leading publications including Fortune, The Economist, the Chicago Tribune, the Chicago Sun-Times, and Small Times. Sean has been very active in nanotechnology trade and economic development issues. He helped to organize and execute the first Nanotechnology Trade Mission to Europe in conjunction with the NanoBusiness Alliance and the U.S. Department of Commerce. He has also been engaged with senior officials of the U.S. Department of Commerce’s Technology Administration on the potential impact of export control issues on nanotechnology development and commercialization. Prior to founding AtomWorks and serving as the Executive Director of the NanoBusiness Alliance, Sean had more than 7 years experience in management consulting, most recently as Engagement Manager at McKinsey & Company. Sean served a variety of Fortune 500 companies, focusing primarily upon the industrial and chemicals sectors. While there, he developed some of the firm’s early perspective on the business opportunities created by the nanotech revolution, publishing the first two internal documents on the subject. Sean received his Masters in Business Administration and Masters in Engineering Management from Northwestern University. He holds a BA in Economics from the University of Notre Dame.
Philip Lippel is an expert consultant on nanoscience and emerging technologies. He has worked on a variety of technical, policy, and science communication issues at the national and international level in fields including nanotechnology, science education and workforce, informatics, telecommunications, and commercialization of emerging technologies. Dr. Lippel has provided top level scientific support to the leadership of the U.S. National Nanotechnology Initiative; helped to keep Congress, the public, and other interested parties up to date on federally funded nanotechnology research and development; and liaised with companies, NGOs, and state agencies interested in nanotechnology commercialization. He was appointed as a U.S. delegate to the Working Party on Nanotechnology at the Organisation for Economic Co-operation and Development, and as a U.S. expert to the ISO/IEC Joint Technical Committee on Information and Communication Technologies. He served government as a senior policy analyst at the National Nanotechnology Coordination Office and as an AAAS Science and Technology Policy Fellow at the National Science Foundation; industry as a Member of Technical Staff at Agilent Technologies and as founder of L Cubed Consulting; and academia as a faculty member in the Physics Department of the University of Texas at Arlington. Dr. Lippel feels privileged to have been an early participant in the emergence of nanotechnology as a discipline, beginning with his use of scanning tunneling microscopes for materials research at the IBM Almaden Research Center and at UT Arlington, and as a tool for introducing college students to nanoscale science at L Cubed. He received an A.B. in Physics and in Theatre from Williams College, and the M.S. and Ph.D. degrees in Physics from Brandeis University.
Kenneth Moss has over 25 years experience in chemical risk management and regulatory policy under the Toxic Substances Control Act (TSCA) and has worked most of that time in EPA’s new chemicals program. He currently leads a notice and regulations team (within the New Chemicals Management Branch and Office of Pollution Prevention and Toxics) that deals with new nanotechnology and biotechnology products. The Branch manages the review and regulation of new chemical substances submitted to the Agency as premanufacture notices (PMNs) under TSCA, and is also responsible for outreach and program policy development and interpretation. Ken holds a Masters degree in cell biology from the University of Virginia, and a Master of Public Health degree from the University of California, Berkeley.
Nina Horne is a policy consultant specializing in innovation and risk policy; she serves on multiple national and international bodies developing nanotechnology standards and policies. As an Invited Expert to the U.S. Delegation to the Organisation of Economic Cooperation and Development (OECD) Working Party on Manufactured Nanomaterials, she has formed a global body of leading scientists assessing the physical and chemical characterization and toxicology to accelerate scientific understanding of potential nanoparticle human health and environmental risk. As an expert advisor to a Technical Advisory Group of the International Standards Organization (ISO), Nina has authored multiple voluntary nanolabeling position drafts under consideration within the global ISO community. Nina also serves on multiple nanotechnology advisory groups in the U.S., California, and the EU. Her work is recognized with fellowships from the EU Center of Excellence and the Institute on Global Conflict and Cooperation. With the United Nations Economic Programme ICLEI, Nina developed carbon efficiency models used by hundreds of U.S. cities to reduce their carbon footprint, which earned her membership in the Clinton Global Initiative University. Nina lectures frequently on innovation, risk, and technology. Nina received her Masters of Public Policy at the Goldman School of Public Policy at the University of California-Berkeley, with an emphasis on science and technology policy and security. Her work in policy follows a career as an academic publisher in advanced biology and earth sciences for the two largest global educational publishers, where she commercialized over a hundred successful products. She also serves as a city commissioner in Oakland, CA.
Mark Owen is the Chief Executive Officer of Puralytics, which he founded in January, 2007 to develop a triple bottom line company built on water purification products based on LED activated nanotechnology. Prior to founding Puralytics, Mr. Owen was the founding CEO of Phoseon Technology, where he managed the development of 8 LED photocuring light source product lines in 5 years as CEO, raised $12m in financing, grew the company to multi-million dollar sales performance, and continues as an active Director. Previously, Mark was the Advanced Product Mgr for Agilent Technologies after the acquisition for $100m of MVT, where he was involved in developing new businesses in automated industrial inspection. Mark was also involved in the formation of a new business unit at ESI making UV laser machining systems that grew to $20m, and now represents over one half of ESI’s corporate revenue. He has >30 patents issued or pending, and greater than $1B in revenues have been derived from products involving his patents. Mr. Owen holds a MAMT degree from the University of Limerick (Ireland) and a BSc Mechanical Engineering degree with honors from Oregon State University.
Mr. Andreev has served as an Executive Vice President and as a Managing Director since March 2005. From 2002 to March 2005, he was an Associate with Draper Fisher Jurvetson (DFJ), a venture capital firm, where he was exclusively focused on nanotechnology and material science investment opportunities. While at DFJ, he played an integral role in sourcing and funding EoPlex, Intematix, Solicore and D-Wave Systems, for which companies he served as an active Board Director or Observer. Previously, he worked for TLcom Capital Partners, a London-based venture capital fund backed by Morgan Stanley. Prior to that, he was employed by Renaissance Capital Group/Sputnik Funds, a venture capital fund in Moscow, Russia. Before he started his business career, he was a researcher at the Centre of Nanotechnology, ISAN (RAS), in Troitsk, Russia, where he was focused on optical and electrical properties of Quantum Dot heterostructures. He was graduated from the Department of Theoretical Physics of Moscow Steel & Alloys Institute (Ph.D.), where he was a recipient of the Scholarship for Outstanding Young Scientists of Russian Academia of Sciences, the Scholarship from the International Center of Fundamental Physics and Soros Scientific Foundation. He also was graduated from Moscow Steel & Alloys Institute (B.S.) with honors in Engineering/Material Sciences and from Stanford Graduate School of Business (M.B.A.). Portfolio responsibilities: CFX Battery, Cobalt BioFuels, C-Switch, D-Wave Systems, Kovio, Molecular Imprints, NanoGram, NeoPhotonics, PolyRemedy and Xradia.
Stephen Wasko is Principal and Owner of Wasko Associates, an operations and financial consulting firm specializing in small to mid-sized company development. He has over 25 years of management experience in the medical diagnostics, advanced materials and nanotechnology, software, telecommunications and aerospace industries. His Wasko Associates practice focuses on high tech and manufacturing companies to develop commercial applications for their technologies, produce business plans, raise capital and implement and improve their commercial operations. Mr. Wasko also served as the CFO for Nanosphere, Inc., a Northbrook, IL life sciences company which uses breakthrough applications of nanotechnology to create new standards in medical care. At Nanosphere, he was responsible for overall financial management and raised over $100 million of investment capital to bring the Company’s products to the medical diagnostics marketplace. Mr. Wasko has served as President and COO of Molecular Diagnostics, Inc., a developer of cancer diagnostic systems; as CFO and head of business development for Perceptual Robotics, Inc., a developer of Internet video software systems; and as Senior VP, Corporate Development and founding CFO of Illinois Superconductor Corporation, where he led the company’s successful Initial Public Offering on the Nasdaq National Market. An engineer by training, Mr. Wasko holds a B.S.E. in aerospace engineering from the University of Michigan, an M.S. in the same field from the University of Southern California, and an M.B.A. from the Harvard Business School
Since joining as CEO in early 2009, Pixelligent has refocused its product strategy, raised $3M in equity, entered into a joint venture with a leading polymer company, and has been awarded nearly $9 million in Federal grant programs. Prior to Pixelligent, Mr. Bandes was the President & CEO of Global Secure Corp, a high- tech homeland security company he grew from a start-up to over 200 people, revenues of $40M, raised $25M+, and acquired three companies. Prior to Global Secure Mr. Bandes was Co-Founder and President of Focus Technology Consulting, a program management and IT staffing firm, where he still serves on the Board. He has negotiated over $300 million in financial and strategic transactions in the US, Asia and Europe. Mr. Bandes currently sits on numerous private company boards, the NanoBusiness Alliance Advisory Board, and is a graduate of Babson College.
Mark Kaczor joined the staff of the University of Illinois in 1990 as the Radiation Protection Manager at the Nuclear Reactor Laboratory in the University’s Department of Nuclear Engineering. In 1995 he received a Senior Reactor Operator’s license (SRO) from the Nuclear Regulatory Commission (NRC) for the University’s Advanced TRIGA Nuclear Reactor, now decommissioned. Mark has been a Technology Manager with the OTM since 2000 and obtained the Certified Licensing Professional (CLP) designation from the Licensing Executives Society (LES) on July 1st 2008. Prior to joining the professional staff at Illinois, Mark worked for 13 years in the commercial nuclear power industry as a Senior Radiation Protection Technician at over 15 different nuclear power plants across the United States. His last employment in commercial nuclear power was as a Radiation Protection Supervisor and Licensing Administrator at the Clinton Power Station in Clinton, Illinois. Mark holds a Bachelor’s Degree, a Juris Doctorate, and is licensed to practice law in New York State. Mark is a Senior Technology Manager with a focus on electronics, micro-nano manufacturing, materials science, and CleanTech. m-kaczor@illinois.edu
